CanniMed Therapeutics Inc (TSE:CMED) insider Saskworks Venture Fund Inc. acquired 21,500 shares of the stock in a transaction dated Friday, July 7th. The shares were bought at an average price of C$8.14 per share, with a total value of C$175,010.00.
Saskworks Venture Fund Inc. also recently made the following trade(s):
- On Thursday, July 13th, Saskworks Venture Fund Inc. bought 126,500 shares of CanniMed Therapeutics stock. The stock was acquired at an average price of C$8.35 per share, with a total value of C$1,056,275.00.
CanniMed Therapeutics Inc (CMED) opened at 10.57 on Wednesday. The stock’s market cap is $240.01 million. The firm has a 50-day moving average price of $9.07 and a 200 day moving average price of $10.55. CanniMed Therapeutics Inc has a 52-week low of $7.32 and a 52-week high of $13.35.
TRADEMARK VIOLATION WARNING: This news story was reported by BBNS and is the sole property of of BBNS. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://baseballnewssource.com/markets/cannimed-therapeutics-inc-tsecmed-insider-saskworks-venture-fund-inc-buys-21500-shares-updated-updated-updated/1196858.html.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.
Receive News & Ratings for CanniMed Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics Inc and related companies with our FREE daily email newsletter.